文献速递免疫规划卫生政策与健康促进

医疗保险受益人中拥有与不拥有处方药保险者的带状疱疹疫苗接种情况

Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage.
PubMed 文献 · Vaccine · 2024-11-22

研究基于2019-2023年全国健康访谈调查,纳入33,578名65岁及以上医疗保险受益人,其中93.5%拥有处方药保险。有处方药保险者接种带状疱疹疫苗的概率高于无保险者(45.2% vs 25.3%)。作者认为《通胀削减法案》仅解决有处方药保险者的费用障碍,实施后接种差异更大。

要点

  • 有处方药保险者带状疱疹疫苗接种率为45.2%,无保险者为25.3%。
  • 无处方药保险者更多见于无大学学位、家庭收入低于贫困线、过去一年未接种流感疫苗或未体检、无固定就医场所者。
  • 作者认为《通胀削减法案》仅覆盖有处方药保险者,实施后疫苗接种差异更大。

核心结论

  • 有处方药保险的医疗保险受益人接种带状疱疹疫苗的概率高于无处方药保险者(45.2% vs 25.3%)。
  • 作者认为《通胀削减法案》仅解决有处方药保险者的费用障碍,实施后疫苗接种差异更大。

研究设计与样本

  • 研究使用2019-2023年全国健康访谈调查数据,纳入65岁及以上、同时参加A和B部分或医疗保险优势计划的医疗保险受益人33,578名。
  • 采用描述性统计检查受益人特征,采用逻辑回归分析带状疱疹疫苗接种与医疗保险处方药保险之间的关联。

主要发现

  • 93.5%的受益人拥有处方药保险。
  • 无处方药保险在无大学学位、家庭收入低于贫困线、过去一年未接种流感疫苗和未体检、无固定就医场所的受益人中出现率更高。
  • 有处方药保险者接种带状疱疹疫苗的概率为45.2%,无处方药保险者为25.3%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Inflation Reduction Act (IRA) eliminated cost sharing for Medicare Part D-covered vaccines but did not address the cost burden faced by Medicare beneficiaries who did not have prescription drug coverage. This study aimed to determine the characteristics of beneficiaries without prescription drug coverage and to assess the association between the receipt of a herpes zoster vaccine and prescription drug coverage status. METHODS: We used the 2019-2023 National Health Interview Survey and included Medicare beneficiaries aged 65 years and older who enrolled in both Parts A and B or a Medicare Advantage plan. Descriptive statistics were used to examine beneficiaries' characteristics. Logistic regressions were used to examine the associations between the receipt of a herpes zoster vaccine and Medicare prescription drug coverage. RESULTS: The study included 33,578 beneficiaries and 93.5 % of beneficiaries had prescription drug coverage. The prevalence of lacking prescription drug coverage was higher among beneficiaries who did not have a college degree, had family income below the poverty level, had no flu shot and well visit within the past year, and had no usual place for care. The probability of receiving a herpes zoster vaccine was higher among beneficiaries with prescription drug coverage than those without prescription coverage (45.2 % versus 25.3 %). CONCLUSIONS: Herpes zoster vaccination disparities between beneficiaries with and without prescription drug coverage existed before the IRA. Because the IRA only addresses the cost barrier facing by beneficiaries with prescription drug coverage, vaccination disparities was greater after the IRA implementation.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Tsai Y, Leung J, Anderson TC, et al. Herpes zoster vaccination among Medicare beneficiaries with and without prescription drug coverage. Vaccine. 2024. PMID: 39579649. doi:10.1016/j.vaccine.2024.126537

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。